Bionet Corp. (1784) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bionet Corp. (1784:TWSE), powered by AI.

Current Price
$66.00
Sector
Healthcare
What is the Bionet Corp. stock price forecast?

Bionet Corp. is currently trading at $66.00. View real-time AI analysis on Alpha Lenz.

What is Bionet Corp. insider trading activity?

View the latest insider trading data for Bionet Corp. on Alpha Lenz.

What is Bionet Corp.'s P/E ratio?

View Bionet Corp.'s valuation metrics on Alpha Lenz.

Bionet Corp.

TWSE · 1784
NT$66.00-0.40(-0.60%)
Ask about Bionet Corp.'s future dividend policy...
Alpha Chat Insight

Bionet Corp.'s ROE is 3.9%. Explore profitability and growth together.

Ask for details

Company Overview

Bionet Corp. is a biotechnology company based in Taipei, Taiwan, specializing in cell therapy, regenerative medicine, and medical big data. Its core businesses encompass stem cell banking—offering storage and applications for various types of stem cells, including mesenchymal, dental, adipose, peripheral blood, and immune cells—as well as genetic and prenatal testing services. The company is also engaged in the development of regenerative medical solutions, such as novel anti-aging therapies and the ANIKINE product line, and is pioneering cell-free treatments like exosome therapy. Beyond these, Bionet provides analytical testing, R&D, and commercializes cell-derived medical products, serving both local and international healthcare markets. Founded in 1989, Bionet Corp. plays an important role in advancing biotechnology capabilities in Taiwan, contributing to developments in diagnostics, therapeutic applications, and health technology innovation for the broader healthcare sector.

SectorHealthcare
IndustryDiagnostics & Research
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$1.24BRevenue
0.00Shares Out
0Employees

Margins

55.30%Gross
6.91%EBITDA
-0.98%Operating
1.56%Pre-Tax
0.07%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

8.05%Rev 3Yr
8.92%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
-74.89%Net Inc 3Yr
-7.39%Net Inc 5Yr

Returns

0.03%ROA
3.95%ROE
0.67%ROIC

Financial Health

NT$256.05MCash & Cash Equivalents
NT$566.54MNet Debt
36.44%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Bionet Corp. (ticker: 1784) is a company listed on TWSE in the Healthcare sector (Diagnostics & Research).

The current price is 66 with a P/E ratio of -x and P/B of -x.

ROE is 3.95% and operating margin is -0.98%. Annual revenue is $1.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Bionet Corp. (1784) Stock Forecast 2026 $66.00 — Price, Financials & Analyst Targets | Alpha Lenz